Quantinuum Inc. Class A Common Stock
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a QNT research report →
Range $50 – $100
Price Chart
About the company
Quantinuum Inc. manufactures and develops quantum computing hardware and software in United States and Internationally. The company develops a quantum computing platform that offers solutions, such as hardware platforms, developer tools, application libraries, and solution-targeted intellectual property.
- CEO
- Rajeeb Hazra
- IPO
- 2026
- Employees
- 700
- HQ
- Broomfield, CO, US
AI snapshot
Six angles, distilled from the data.
The stock is in a deep post-IPO reset, trading well below both the 50-day and 200-day moving averages. It remains far off the 52-week high of 86.79 and is still above the 52-week low of 28.31, leaving the chart in a damaged but not broken range.
Street sentiment is constructive, with an 8-to-0 Buy consensus and an average target of 78.8, well above the current share price. Recent action has been mixed but still supportive: several firms trimmed targets, while BTIG initiated coverage at Buy and Morgan Stanley upgraded to Overweight.
The earnings profile is improving on execution, not on profitability yet. The last quarter delivered a 52.5% EPS beat versus estimates, but full-year estimates still point to losses, with 2026 EPS expected at -1.49 and 2027 at -1.60. Shareholders should watch whether revenue growth can outpace continued cash burn.
No discretionary insider buying or selling stands out. Recent filings are dominated by award-related activity for Robin Schulman and non-trading entries from Honeywell, which read more like compensation or ownership housekeeping than a directional signal.
Gross margin is solid at 46.7%, but operating leverage remains weak with an operating margin of -28.3351%. Revenue growth is positive at 2.333% year over year, while free cash flow was -85.196 million in 2025, offset by a strong net cash position of 757.959 million.
Quantinuum’s edge is its integrated quantum hardware-plus-software platform, but the market is still pricing it like a pre-scale story. Versus software peers, the valuation is rich on a negative earnings base, with the current setup relying on long-duration growth rather than near-term earnings power.
Similar companies
Peers in the same neighborhood.
- Market Cap
- $7.30B
- P/E
- -32.14
- PEG
- -0.25
- P/S
- 1792.77
- P/B
- 2.27
- EV/EBITDA
- -42.85
- Div Yield
- 0.00%
- Gross Margin
- 20.47%
- Op Margin
- -4168.58%
- Net Margin
- -482.06%
- ROE
- -19.09%
- ROIC
- -40.62%
Latest fiscal year · YoY change
- Revenue
- $30.93M+34.6%
- Gross Profit
- $19.23M+58.0%
- Op Income
- $-530,053,000
- Net Income
- $-71,530,000+50.4%
- EPS
- $-2.15+48.3%
- OCF Growth
- -32.6%
- FCF Growth
- -74.5%
- 52W High
- $86.79
- 52W Low
- $27.11
- 50D MA
- $40.56
- 200D MA
- $51.74
- Beta
- 2.08
- RSI (14)
- 36
- Avg Volume
- 2.19M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Quantinuum reported a strong Q3 with revenue up sharply, record logical-fidelity progress in Helios, and raised full-year 2026 revenue guidance as commercial momentum broadened across cloud, government, and enterprise customers.· November 5, 2026
- Q3 revenue was $9.1 million, up 233% year over year; non-GAAP gross margin was 74.6% and bookings were $98 million.
- Management said Helios achieved world-record logical fidelity in September and October, including 99.9995% logical fidelity in October, or five errors per one million operations.
- The company raised full-year 2026 revenue guidance to $31 million-$34 million from $28 million-$32 million and still expects more than 100% revenue growth in 2027.
- Quantinuum said it signed its largest cloud agreement ever, expanded Oracle-related commercialization, and added another hyperscaler partnership.
- Cash ended the quarter at over $1.9 billion with no debt, and management said the balance sheet is sufficient to fund the roadmap toward fault tolerance.
Revenue was $9.1 million in Q3, up 233% year over year. Non-GAAP gross margin was 74.6%, and bookings were $98 million in the quarter, bringing 2026 year-to-date bookings to approximately $104 million. Cost of sales was $3.2 million; R&D was $97.5 million; sales and marketing was $14.9 million; G&A was $22.1 million. Adjusted EBITDA was a loss of $80.5 million, GAAP net loss was $117.9 million, and non-GAAP net loss was $75.2 million, or $0.29 per share. The company ended with over $1.9 billion in cash and equivalents and no debt. Full-year 2026 revenue guidance was raised to $31 million-$34 million from $28 million-$32 million previously, and management reiterated expectations for more than 100% revenue growth in 2027.
Raj Hazra framed the quarter as evidence that Quantinuum is moving from technical promise toward practical commercial impact. He emphasized a full-stack strategy spanning hardware, software, and ecosystem partnerships, highlighted record logical-fidelity results on Helios, and said those results significantly de-risk the path to Apollo in 2029. His tone was confident and expansive, with repeated references to leadership in fault-tolerant quantum computing and accelerating momentum into 2027 and beyond.
Nitesh Sharan focused on the acceleration in both commercial traction and near-term financial performance. He cited $9.1 million of revenue, $98 million of bookings, 74.6% non-GAAP gross margin, and over $1.9 billion in cash with no debt, while noting that stock-based compensation totaled $37.2 million and adjusted EBITDA loss was $80.5 million. He said the business is funded from a position of capital strength, the CHIPS award was finalized as a $100 million equity contract that does not hit the P&L, and management is raising 2026 revenue guidance to $31 million-$34 million while still expecting more than 100% growth in 2027.
Analysts pressed on what specifically drove the higher 2026 outlook, and management said the improvement was broad-based across cloud, government, and enterprise, in the U.S. and internationally, with traction in financial services, chemicals, and pharma. They also asked how the new logical-fidelity results affect Apollo and Lumos; management said the lower error rates mean significantly fewer physical qubits are needed, improving scalability and giving confidence in the 2029 Apollo timeline. Questions on the largest cloud deal and hyperscaler partnerships focused on monetization and customer behavior; management said these are strategic go-to-market arrangements that increasingly cover multi-year, multi-generation commitments and are already seeing contract expansion and movement from research toward application development.
The bull case from this call is that Quantinuum appears to be translating technical leadership into tangible commercial momentum. Management pointed to record error-correction results, a clear roadmap to Sol and Apollo, a growing Nexus user base, and major customer and cloud wins that are already broadening bookings and improving confidence in 2027 revenue growth. Cash remains very strong at over $1.9 billion with no debt, supporting continued investment.
The main risks discussed were that the business is still early-stage, revenue remains small at $9.1 million, and expenses are very high relative to revenue, with a $80.5 million adjusted EBITDA loss in the quarter. Management also acknowledged that timing can be uneven, Sol is not expected to be commercially available until the second half of 2027, and many expected benefits are still tied to future hardware milestones, contract timing, and revenue recognition. The company is also still working through aspects of hyperscaler economics and DARPA Stage C scope, so some commercialization paths remain in progress rather than fully locked in.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 91.4%
- Shares Outstanding
- 36.89M
- Float Shares
- 33.71M
of shares held by institutions
184 13F filers
Congressional trading
Senate and House stock disclosures for QNT, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Cleo FieldsHouse · LA06 | Buy | Jun 4, 26 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Capital World Investors | 4.92M | ▲ 361.38K |
| Blackrock, Inc. | 2.85M | ▲ 593.20K |
| Voya Investment Management LLC | 1.68M | ▲ 989.88K |
| Defiance Etfs, LLC | 1.33M | ▲ 110.51K |
| Vanguard Capital Management LLC | 1.27M | ▲ 323.85K |
| Penserra Capital Management LLC | 1.20M | ▲ 1.20M |
| Capital International Investors | 1.02M | ▲ 60.32K |
| Vanguard Portfolio Management LLC | 1.01M | ▼ 14.02K |
| Wellington Management Group Llp | 981.54K | ▼ 149.10K |
| Fil Ltd | 954.85K | ▲ 288.08K |
| Ubs Group AG | 837.09K | ▲ 710.20K |
| Capital Research Global Investors | 833.37K | ▼ 920.96K |
Held by 219 ETFs
Biggest fund positions in QNT by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 17, 26 | O'Byrne Rory Gordon | other | 0 |
| Jul 17, 26 | Schulman Robin | other | 125,000 |
| Jul 17, 26 | Schulman Robin | other | 78,125 |
| Jul 17, 26 | Schulman Robin | other | 0 |
| Jun 4, 26 | HONEYWELL INTERNATIONAL INC | other | 0 |
| Jun 4, 26 | HONEYWELL INTERNATIONAL INC | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our QNT coverage
Recent articles, reports, and earnings notes.

Quantinuum Inc. Class A Common Stock (QNT) rises 6.6%
Quantinuum Inc. Class A Common Stock (QNT) rises after fresh Japan partnership news with RIKEN and SoftBank extends momentum from strong quarterly results. The stock is trading on heavier volume as investors weigh rapid revenue growth, an improved outlook, and the company’s still-high valuation.

Quantinuum IPO: The Bull and Bear Case for Quantum Scale
Quantinuum Inc. is expected to list on NASDAQ on 2026-06-04, with shares priced at $45.00 to $50.00. The deal centers on a company trying to turn quantum computing from a research story into a commercial platform. The bull case is a large, integrated quantum stack with strong strategic backing; the bear case is heavy losses, a still-early market, and a valuation that assumes a lot of future execution.
Want a deeper read on QNT?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
QNT & QBTS: 2 Quantum Stocks to Buy for Triple-Digit Growth in 2027
zacks.com · Nov 20
Buy, Sell, or Hold? Thursday’s Top Upgrades and Downgrades: Advanced Micro Devices, Alibaba Group, Cleveland-Cliffs, Conoco Phillips, Diamondback Energy, General Mills, NVIDIA, Toyota, Wendy’s and More
247wallst.com · Nov 12
Quantinuum Shares Just Leapt 26%. Is the Stock Still a Buy?
fool.com · Nov 10
Quantinuum Stock Moves Higher: What's Going On?
benzinga.com · Nov 10
Quantinuum and RIKEN Expand Partnership to Accelerate the Commercialization of Quantum-AI Hybrid Supercomputing in Japan
prnewswire.com · Nov 10
Quantinuum nimmt an der 4. Annual Crypto, FinTech, AI & Energy Infrastructure Conference von Cantor Convergence teil
prnewswire.com · Nov 9
Quantinuum to Participate in the Cantor Convergence 4th Annual Crypto, FinTech, AI & Energy Infrastructure Conference
prnewswire.com · Nov 9
QNT Q3 Earnings Call Highlights Raised Outlook and Quantum Progress
zacks.com · Nov 9
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
AI analysis · Last refreshed November 17, 2026 · Live quote · Not investment advice